Albany, NY -- (SBWIRE) -- 10/04/2017 -- This report on insulin delivery devices market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of insulin delivery devices such as insulin pen and insulin pumps as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global insulin delivery devices market with respect to the leading market segments based on major products segment, distribution channels, and geographies.
Click to get sample PDF with TOC: https://www.researchmoz.us/enquiry.php?type=S&repid=1315165
Global Insulin Delivery Devices Market: Key Segments
Based on the product type, the insulin delivery devices market has been segmented into: insulin syringe, insulin pens, insulin pumps, and others (insulin patches & needle free injection jet). Each of the market segments have been extensively analyzed based on the market related factors such as increasing rate of diabetes incidences worldwide, technological advancement, and growing number of use of insulin delivery devices in various geographies. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
Global Insulin Delivery Devices Market: Trends and Opportunities
The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the insulin delivery devices market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global insulin delivery devices market.
Global Insulin Delivery Devices Market: Geographical Segmentation
Geographically, insulin delivery devices market has been segmented into five major regions: North America, Europe, Asia, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter's five forces analysis, value chain analysis, pricing analysis and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global insulin delivery devices market.
The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global insulin delivery devices market.
Global Insulin Delivery Devices Market: Competitive Landscape
The report also profiles key players operating in the insulin delivery devices market which are B. Braun Melsungen AG, Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Medtronic plc., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Biocon Ltd., Owen Mumford Ltd., Cellnovo Group SA., Animas Corporation (Johnson & Johnson , Tandem Diabetes Care, Inc., Other Prominent Players.
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Albany NY - 12207
Tel: 866-997-4948 (Us-Canada Toll Free)
Follow us on LinkedIn at: http://bit.ly/1TBmnVG